Ligand (LGND) analyst forecast and price target
Analyst forecast
Consensus of 10 analyst ratings
Based on 7 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Leerink Partners | Initiated Coverage | Outperform | $330.00 | Aug 14, 2026 |
| RBC Capital | Maintained | Outperform | $345.00 from $340.00 | Aug 7, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $358.00 from $289.00 | Aug 6, 2026 |
| Oppenheimer | Maintained | Outperform | $326.00 from $285.00 | Aug 3, 2026 |
| Citigroup | Maintained | Buy | $387.00 | Jul 21, 2026 |
| RBC Capital | Maintained | Outperform | $340.00 from $262.00 | Jul 15, 2026 |
| B of A Securities | Maintained | Buy | $388.00 from $266.00 | Jul 9, 2026 |
| Stifel | Maintained | Buy | $332.00 from $255.00 | Jul 8, 2026 |
| RBC Capital | Maintained | Outperform | $262.00 from $252.00 | May 8, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $289.00 from $243.00 | Apr 30, 2026 |
| RBC Capital | Maintained | Outperform | $252.00 from $235.00 | Apr 28, 2026 |
| Citigroup | Maintained | Buy | $282.00 from $276.00 | Apr 15, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $243.00 from $239.00 | Apr 14, 2026 |
| Citigroup | Maintained | Buy | $276.00 from $270.00 | Mar 24, 2026 |
| B of A Securities | Initiated Coverage | Buy | $244.00 | Mar 11, 2026 |
| Oppenheimer | Maintained | Outperform | $277.00 from $275.00 | Feb 27, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $239.00 from $231.00 | Feb 24, 2026 |
| Stifel | Maintained | Buy | $230.00 from $220.00 | Dec 10, 2025 |
| RBC Capital | Maintained | Outperform | $235.00 from $234.00 | Dec 10, 2025 |
| Citigroup | Initiated Coverage | Buy | $270.00 | Dec 9, 2025 |
Frequently asked questions
What is the price target for LGND stock?
The average 12-month analyst price target for Ligand (LGND) is $352.29, with a high estimate of $388.00 and a low of $326.00, across 7 analysts.
Is LGND a buy, sell, or hold?
Analysts covering Ligand currently average a Buy rating: 10 buy, 0 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for LGND?
The average price target of $352.29 implies 24.23% upside from the last price of $283.57.
What is the latest analyst rating on LGND?
On Aug 14, 2026, Leerink Partners initiated coverage of Ligand at Outperform with a price target of $330.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.